Abstract
8-Hydroxy(di-n-propylamino)tetralin (8-OH-DPAT; 0.1-50 mg/kg i.p.) evoked a dose-dependent mydriatic response in conscious mice (ED50 = 5.8 mg/kg i.p.) which was maximal after 10 min. 8-OH-DPAT (2 mg/kg i.p.)-induced mydriasis was attenuated by the alpha 2-adrenoceptor antagonists, idazoxan (1 and 3 mg/kg i.p.) and yohimbine (1 and 3 mg/kg i.p.), by the 5-HT1 receptor antagonists, pindolol (10 mg/kg i.p.) and quipazine (2 mg/kg i.p.), and by the selective 5-HT1A receptor antagonist, (-)-N-tert-butyl-3-[4-(2-methoxyphenyl)piperazin-1-yl]-2-phenyl propionamide ((-)-WAY 100135; 1-10 mg/kg s.c.). These data argue that both central alpha 2-adrenoceptors and 5-HT1A receptors are involved in the mediation of mydriasis induced by 8-OH-DPAT. The synaptic location of these receptors was determined using either N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4; 100 mg/kg i.p.) or 5,7-dihydroxytryptamine (5,7-DHT; 75 micrograms i.c.v.)+p-chlorophenylalanine (PCPA; 200 mg/kg i.p.); these lesioning procedures respectively produced highly significant losses of whole brain noradrenaline (72% depletion) and 5-HT (78% depletion). The former abolished 8-OH-DPAT (5 mg/kg i.p. (ED50)) mydriasis, whereas the latter was without effect. 8-OH-DPAT (0...Continue Reading
References
Jan 1, 1992·Psychopharmacology·D J Sanger, H Schoemaker
Sep 1, 1992·British Journal of Pharmacology·K F MartinD J Heal
Aug 1, 1991·British Journal of Pharmacology·D J HealW R Buckett
Jun 25, 1991·European Journal of Pharmacology·R B McCallK A King
Mar 1, 1989·British Journal of Pharmacology·D J HealW R Buckett
Oct 24, 1989·European Journal of Pharmacology·D J HealW R Buckett
Feb 1, 1986·Journal of Pharmacological Methods·M C Koss
Dec 1, 1985·Neuropharmacology·G M GoodwinA R Green
Jan 1, 1988·Pharmacology, Biochemistry, and Behavior·J C Winter
Dec 1, 1985·Neuropharmacology·D J HealA Metz
Nov 1, 1984·Neuropharmacology·D J Heal
May 4, 1984·European Journal of Pharmacology·M HamonA S Horn
May 20, 1983·European Journal of Pharmacology·D N Middlemiss, J R Fozard
Aug 17, 1984·European Journal of Pharmacology·H Hallman, G Jonsson
May 1, 1982·Neuropharmacology·L L Martin, E Sanders-Bush
Mar 1, 1994·Neuropharmacology·C RoutledgeC T Dourish
Jun 24, 1993·European Journal of Pharmacology·A FletcherY Reilly
Apr 1, 1993·Pharmacology, Biochemistry, and Behavior·J C Winter, R A Rabin
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M RuatJ C Schwartz
Sep 1, 1993·Neuron·T W LovenbergB W Siegel
Mar 1, 1993·British Journal of Pharmacology·G P LuscombeD J Heal
Sep 1, 1964·Acta Physiologica Scandinavica·A DAHLSTROEMT MALMFORS
Jan 1, 1991·Journal of Psychopharmacology·S L DickinsonB Gadie
Citations
Jun 16, 2012·Psychopharmacology·Cédric M Hysek, Matthias E Liechti
Sep 22, 2010·European Journal of Clinical Pharmacology·Oliver KummerStephan Krähenbühl
Mar 23, 2004·European Journal of Pharmacology·Peter B HedlundPascal Bonaventure
Mar 18, 2004·Neuroscience·P BonaventureP B Hedlund
Jul 22, 1999·European Journal of Pharmacology·M Honda, H Ono
Jul 13, 2000·Psychiatry Research·K N SokolskiE M DeMet
Nov 7, 1998·Behavioural Brain Research·A W Deckel, L Fuqua
Apr 28, 1999·Neuropharmacology·E Hajós-KorcsokT Sharp
Sep 16, 2008·Brain Research·Joanna DabrowskaRyszard Brus
Apr 21, 2007·European Journal of Pharmacology·Mariana P ZeidanNelson H Gabilan
Dec 29, 2004·Autonomic Neuroscience : Basic & Clinical·Yongxin Yu, Michael C Koss
Apr 17, 2004·European Journal of Pharmacology·Yongxin YuMichael C Koss
Jun 27, 2006·Biochemical Pharmacology·Joanna Dabrowska, Michal Brylinski
May 9, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Joanna DabrowskaRyszard Brus
Dec 7, 2016·Behavioural Pharmacology·Manato KotaniKazuhito Ikeda
Nov 17, 2016·Frontiers in Behavioral Neuroscience·Christian R Lee, David J Margolis
Jan 9, 2019·Frontiers in Neurology·Elemer Szabadi
Nov 14, 2020·Current Biology : CB·Fanny CazettesZachary F Mainen
Oct 28, 2019·Neuroscience·Tanya Calvey